Chemomab Therapeutics Ltd. (CMMB)

Chemomab Therapeutics Statistics

Total Valuation

CMMB has a market cap or net worth of $10.22 million. The enterprise value is $407,082.

Market Cap	10.22M
Enterprise Value	407,082

Important Dates

The last earnings date was Thursday, November 20, 2025, before market open.

Earnings Date	Nov 20, 2025
Ex-Dividend Date	n/a

Share Statistics

CMMB has 6.16 million shares outstanding. The number of shares has increased by 63.31% in one year.

Current Share Class	n/a
Shares Outstanding	6.16M
Shares Change (YoY)	+63.31%
Shares Change (QoQ)	+6.65%
Owned by Insiders (%)	14.06%
Owned by Institutions (%)	10.97%
Float	5.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.93
P/TBV Ratio	0.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.49

Current Ratio	10.49
Quick Ratio	10.36
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -73.21% and return on invested capital (ROIC) is -48.43%.

Return on Equity (ROE)	-73.21%
Return on Assets (ROA)	-40.61%
Return on Invested Capital (ROIC)	-48.43%
Return on Capital Employed (ROCE)	-96.22%
Revenue Per Employee	n/a
Profits Per Employee	-$504,250
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.92% in the last 52 weeks. The beta is 0.55, so CMMB's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	-78.92%
50-Day Moving Average	2.54
200-Day Moving Average	3.83
Relative Strength Index (RSI)	25.37
Average Volume (20 Days)	105,018

Short Selling Information

Short Interest	8,994
Short Previous Month	12,825
Short % of Shares Out	0.15%
Short % of Float	n/a
Short Ratio (days to cover)	0.09

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.81M
Pretax Income	-10.09M
Net Income	-10.09M
EBITDA	-10.76M
EBIT	-10.81M
Earnings Per Share (EPS)	-$1.67

Balance Sheet

The company has $10.06 million in cash and n/a in debt, giving a net cash position of $10.06 million or $1.63 per share.

Cash & Cash Equivalents	10.06M
Total Debt	n/a
Net Cash	10.06M
Net Cash Per Share	$1.63
Equity (Book Value)	11.23M
Book Value Per Share	1.82
Working Capital	10.79M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMMB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-63.31%
Shareholder Yield	-63.31%
Earnings Yield	-96.39%
FCF Yield	n/a

Analyst Forecast

The average price target for CMMB is $26.50, which is 1,496.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$26.50
Price Target Difference	1,496.39%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-48.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 26, 2025. It was a reverse split with a ratio of 1:4.

Last Split Date	Aug 26, 2025
Split Type	Reverse
Split Ratio	1:4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1